Compass Therapeutics, Inc. revenue

Compass Therapeutics, Inc.'s revenue was $0 in fiscal 2025, down 100.0% on the year before.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Compass Therapeutics, Inc.: revenue history, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	0	850	0
Growth on the year before	—	—	−100.0%

US$ thousands unless shown otherwise. Fiscal quarters.

Compass Therapeutics, Inc.: revenue history, quarterly
Quarter	2023 Q3Sept 2023	2023 Q4Dec 2023	2024 Q2Jun 2024	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025
Revenue	0	0	850	0	0	0	0	0
Growth on the same quarter a year before	—	—	—	—	—	—	−100.0%	—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Compass Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Compass Therapeutics, Inc.